I now have comprehensive information from multiple standard ENT textbooks. Let me compile the complete, PG exam-focused notes.
Otoacoustic Emissions (OAE) - PG Exam Notes
Sources: Cummings Otolaryngology, KJ Lee's Essential Otolaryngology, Shambaugh Surgery of the Ear, Scott-Brown's Otorhinolaryngology
1. Definition
- OAEs are low-intensity sounds generated by the cochlear outer hair cells (OHCs) that travel backward through the middle ear into the external ear canal, where they are recorded by a sensitive microphone.
- They are an epiphenomenon - a byproduct of active OHC processing, NOT a process of hearing itself.
- First described by David Kemp (1978) - hence sometimes called "Kemp echoes" or "cochlear echoes."
2. Mechanism / Pathway of Energy
OHC motility → Basilar membrane → Cochlear fluids → Oval window → Ossicles → Tympanic membrane (acts as loudspeaker) → External ear canal
- The active motility (electromotility) of OHCs amplifies displacement of the cochlear partition, producing these acoustic by-products.
3. Prerequisites for Recording OAE
For OAEs to be recorded, the following must be intact:
- Functioning OHCs (cochlear integrity)
- Normal middle ear function (both for sound to reach the cochlea AND for OAE energy to travel back out)
- Patent external ear canal (no obstruction/wax)
- Quiet environment (not necessarily sound-treated, but quiet)
- Still and calm patient (no behavioral response needed)
Key Point: OAEs are absent in conductive hearing loss not because OHCs are damaged, but because the middle ear blocks the outgoing emission.
4. Classification of OAEs
A. Spontaneous OAEs (SOAEs)
- Occur without any external stimulus
- Present in 35-60% of normally hearing individuals
- Absence is non-diagnostic (absent even in many normal ears)
- Not reliably correlated with tinnitus
- Rarely used clinically
B. Evoked OAEs (EOAEs) - Clinically Important
i. Transient Evoked OAEs (TEOAEs)
| Feature | Detail |
|---|
| Stimulus | Broadband click or brief tone burst at ~80-85 dB SPL |
| Frequency range | 0.4 - 6 kHz (practically up to 4 kHz in clinical use) |
| Latency | 5-20 ms (response begins ~4 ms, continues ~10 ms after stimulus) |
| Response | Low-intensity (~30 dB lower than stimulus) |
| Interpretation | Present/Absent by octave band |
| Threshold indicator | Present TEOAE = cochlear hearing no worse than 30-40 dB HL |
| Analysis | Reproducibility % - if >50% reproducible AND signal exceeds noise floor, OAE is "present" |
ii. Distortion Product OAEs (DPOAEs)
| Feature | Detail |
|---|
| Stimulus | Two simultaneous pure tones (f1 and f2) |
| Key formula | Most prominent DP at 2f1 - f2 (cubic difference tone) |
| f1/f2 ratio | Best at f2/f1 = 1.2 |
| Stimulus levels | f1 = 65 dB SPL, f2 = 55 dB SPL (or both 55-65 dB SPL) |
| Frequency range | ~1000 - 6000 Hz (broader than TEOAE) |
| Amplitude | ~60 dB lower than primary tones |
| Advantage | Frequency-specific; can sometimes be recorded even in moderate-to-severe hearing loss |
| Output | DP-gram (amplitude vs. frequency of f2) |
iii. Stimulus Frequency OAEs (SFOAEs)
- Elicited by a continuous pure tone stimulus
- Rarely used clinically
5. TEOAE vs DPOAE - Quick Comparison (PG Favorite)
| Feature | TEOAE | DPOAE |
|---|
| Stimulus | Click / tone burst | 2 simultaneous pure tones (f1 + f2) |
| Key frequency | 2f1 - f2 | Broadband (same as click) |
| Frequency specificity | Less specific | More specific |
| Threshold sensitivity | Absent if >30-40 dB SNHL | Can persist in moderate SNHL |
| Clinical use | Newborn screening (preferred) | Ototoxicity monitoring, noise-induced HL |
| Test time | ~5-10 min per ear | ~5-10 min per ear |
| Environment | Quiet (not sound-treated) | Quiet (not sound-treated) |
6. What OAE Tests - and What It Does NOT Test
OAE TESTS:
- Outer hair cell (OHC) function only
- Cochlear integrity at specific frequency regions
- Presence/absence of >30-40 dB cochlear hearing loss
OAE DOES NOT TEST:
- Inner hair cells (IHC)
- Auditory nerve / retrocochlear pathway
- Central auditory processing
- Hearing thresholds precisely
Critical PG Point: Retrocochlear lesions (e.g., acoustic neuroma) = OAE normal, ABR abnormal
7. Interpretation Pattern for PG Exams
| Finding | Interpretation |
|---|
| OAE present + ABR normal | Normal hearing |
| OAE absent + normal middle ear | Cochlear (OHC) damage, >30-40 dB SNHL |
| OAE absent + abnormal tympanogram | Conductive hearing loss (middle ear problem) |
| OAE present + ABR absent | Auditory Neuropathy Spectrum Disorder (ANSD) |
| OAE present + behavioral hearing loss | Suspect non-organic/functional hearing loss |
8. Auditory Neuropathy Spectrum Disorder (ANSD) - High Yield
- Hallmark: Normal OAEs (intact OHCs) + absent/grossly abnormal ABR
- Cochlear microphonic (CM) may be present (wave I of ABR)
- Site of lesion: IHCs, auditory nerve, or synaptic junction
- OAE may disappear over time even in ANSD
- Management: Cochlear implant often beneficial
9. Clinical Applications of OAE
| Application | Type Used |
|---|
| Newborn hearing screening (NHS) | TEOAE (preferred) or DPOAE |
| Ototoxicity monitoring (cisplatin, aminoglycosides) | DPOAE (frequency specific) |
| Noise-induced hearing loss monitoring | DPOAE |
| Diagnosis of ANSD | TEOAE or DPOAE |
| Differential: cochlear vs retrocochlear | OAE (present in retrocochlear) |
| Intraoperative monitoring (vestibular schwannoma) | Occasionally OAE |
| Non-organic/malingering detection | OAE (objective test) |
| Tinnitus evaluation | Limited role (some correlation with SOAEs) |
10. Newborn Hearing Screening - OAE Role
- Universal Neonatal Hearing Screening (UNHS) uses automated OAE (AOAE) as the first-line tool
- Two protocols:
- 1-step: OAE alone or AABR alone
- 2-step: OAE first → AABR for those who fail OAE ("refer")
- OAE cannot detect ANSD → high-risk newborns (NICU, hyperbilirubinemia, ototoxic drugs) should also have AABR
- Refer criterion: If OAE absent in well-baby nursery, rescreen within 1 month; if still refers, full audiologic assessment
PG Note: If newborn screened with OAE only and has ANSD, they will PASS OAE but have hearing dysfunction - this is why AABR is added in high-risk groups.
11. Factors Affecting OAE Recording
| Factor | Effect |
|---|
| Middle ear effusion / OME | Absent OAE (most common cause in children) |
| Cerumen/debris in canal | Absent/reduced OAE |
| Probe fit | Critical - poor seal gives absent/unreliable results |
| Background noise | Raises noise floor, may mask OAE |
| Cochlear SNHL >30-40 dB | Absent OAE |
| Sedation | NOT required (patient just needs to be still) |
| Crying/movement | Increases noise, reduces reliability |
12. Advantages of OAE Over ABR
- Faster - 5-10 minutes per ear vs. 30-60 minutes for ABR
- No sedation needed in most cases
- Simpler setup - probe placement only, no electrodes
- Objective - no behavioral response required
- Specific to OHC/cochlear function
13. Limitations of OAE
- Does NOT assess auditory nerve or central pathways
- Affected by middle ear pathology (false negatives)
- Cannot give precise hearing thresholds
- Will miss ANSD if used alone for screening
- High refer rate in first 24-48 hours of life (fluid/debris in canal)
14. Quick Memory Tables
OAE Type - Stimulus - Frequency (3-line memory trick)
- SOAE = No stimulus, narrowband peaks, present in ~50% normal ears
- TEOAE = Click → broad response, 0.4-6 kHz, latency 5-20 ms
- DPOAE = Two tones (f1, f2) → 2f1-f2, frequency specific, 1-6 kHz
Key Numbers to Remember
- OAE absent when SNHL > 30-40 dB
- SOAE present in 35-60% of normal ears
- TEOAE latency: 5-20 ms
- DPOAE formula: 2f1 - f2
- DPOAE f2/f1 ratio: 1.2
- DPOAE amplitude: ~60 dB lower than primary tones
- Test time: 5-10 min per ear
- TEOAE stimulus level: ~80-85 dB SPL
Sources: Cummings Otolaryngology Head & Neck Surgery (5th ed.) | KJ Lee's Essential Otolaryngology (11th ed.) | Shambaugh Surgery of the Ear (6th ed.) | Scott-Brown's Otorhinolaryngology Vol. 1 & 2